Abstract

Research Article

Immunohistochemical expression of Nestin as Cancer Stem Cell Marker in gliomas

Rasha Mokhtar Abdelkareem*, Afaf T Elnashar, Khaled Nasser Fadle and Eman MS Muhammad

Published: 11 November, 2019 | Volume 3 - Issue 2 | Pages: 162-166

Background: Gliomas represent the most frequent primary tumors of central nervous system (CNS), contributing to more than half of the incidence of brain tumors. Cancer stem cell markers (CSC) identify a group of patients at high risk for progression. Nestin is an intermediate filament (IF) protein was first described as a neural stem cell/progenitor cell marker. Nestin-positive neuroepithelial stem cells are detected in the subventricular zone of the human adult brain and they remain mitotically active throughout adulthood. The expression of Nestin in gliomas has been suggested to be related to dedifferentiation, improved cell motility, invasive potential and increased malignancy. This study aims to investigate Nestin immunohistochemical expression in different types of glioma and its correlation with different clinicopathological parameters.

Materials and Methods: Nestin immunostaining was studied in 60 specimens of glioma using avidin-biotin peroxidase method.

Results: Nestin was strongly expressed in 11/60 (18.33%), moderately expressed in 29/60 (48.33%) and weekly expressed in 15/60 (25%) of studied gliomas. A significant positive correlation was found between Nestin expression and histologic type (p < 0.001) and increasing grade of gliomas (p < 0.001).

Conclusion: Increased Nestin expression is correlated with tumor progression, increasing grade and poor prognostic parameter of glioma. Nestin is a useful marker for detection of CSC in high-grade glioma which is responsible for resistance to chemo-radiotherapy and may serve as a predictor for patient outcomes.

Read Full Article HTML DOI: 10.29328/journal.jnnd.1001027 Cite this Article Read Full Article PDF

Keywords:

Nestin; Cancer stem cell; Gliomas

References

  1. Tadej S. Prognostic Significance of Immunohistochemical Markers in Glioma Patients. Advances in the Biology, Imaging and Therapies for Glioblastoma. 2011; 284-285.
  2. Sanai N, Chang S, Berger MS. Low grade gliomas in adults. J Neurosurg. 2011; 115: 948-965. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22043865
  3. Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012. Neuro-oncol. 2015; 17: 1-62. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26511214
  4. Ibrahim AS, Khaled HM, Mikhail NNH, Baraka H, Kamel H. Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program. J Cancer Epidemiol. 2014; 437971: 1-18. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25328522
  5. Li SC, Vu LT, Ho HW, Yin HZ, Keschrumrus V, et al. Cancer stem cells from a rare form of glioblastoma multiforme involving neurogenic ventricular wall. Cancer Cell Int. 2012; 12: 41. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22995409
  6. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de TN, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005; 352: 997-1003. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15758010
  7. Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, et al. Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res. 2008; 68: 6043-6048. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18676824
  8. Murre C. Helix–loop–helix proteins and the advent of cellular diversity: 30 years of discovery. Genes & Dev. 2019; 33: 6-25. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30602438
  9. Dahlrot RH, Hermansen SK, Hansen S, Kristensen BW. What is the clinical value of cancer stem cell markers in gliomas? Int J Clin Exp Pathol. 2013; 6: 334-348. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23412423
  10. Zhang M, Song T, Yang L, Chen R, Wu L, et al. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res. 2008; 27: 8. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19108713
  11. Ishiwata T, Matsuda Y, Naito Z. Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis. World J Gastroenterol. 2011; 17: 409-418. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21274370
  12. Dahiya S, Lee da Y, Gutmann DH. Comparative characterization of the human and mouse third ventricle germinal zones. J Neuropathol Exp Neurol. 2011; 70: 622-633. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21666496
  13. Lépinoux-Chambaud C, Eyer J. Review on intermediate filaments of the nervous system and their pathological alterations. Histochem Cell Biol. 2013; 140: 13-22. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23749407
  14. Arai H, Ikota H, Sugawara K, Nobusawa S, Hirato J, et al. Nestin expression in brain tumors: it's utility for pathological diagnosis and correlation with the prognosis of high-grade gliomas. Brain Tumor Pathol. 2012; 29: 160-167.
  15. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO Classification of Tumors of the Central Nervous System. Revised 4th ED. Lyon: IARC. 2016.
  16. Strojnik T, Rosland GV, Sakariassen PO, Kavalar R, Lah T. Neural stem cell markers, Nestin and musashi proteins, in the progression of human glioma: correlation of Nestin with prognosis of patient survival. Surg Neurol. 2007; 68: 133-143. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17537489
  17. Ma YH, Mentlein R, Knerlich F, Kruse ML, Mehdorn HM, et al. Expression of stem cell markers in human astrocytoma of different WHO grades. J Neurooncol. 2008; 86: 31-45. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17611714
  18. Kitai R, Horita R, Sato K, Yoshida K, Arishima H, et al. Nestin expression in astrocytic tumors delineates tumor infiltration. Brain Tumor Pathol. 2010; 27: 17-21. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20425043
  19. Wan F, Herold-Mende C, Campos B, Centner FS, Dictus C, et al. Association of stem cell-related markers and survival in astrocytic gliomas. Biomarkers. 2011; 16: 136-143. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21323603
  20. Hatanpaa KJ, Hu T, Vemireddy V, Foong C, Raisanen JM, et al. High expression of the stem cell marker Nestin is an adverse prognostic factor in WHO grade II–III astrocytoma and oligoastrocytomas. J Neuro oncol. 2014; 117: 183-189. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24519516
  21. Lin A, Marchionni L, Sosnowski J, Berman D, Eberhart CG, et al. Role of Nestin in glioma invasion. World J Transl Med. 2015; 4: 78-87.
  22. Rani SB, Mahadevan A, Anilkumar SR, Raju TR, Shankar SK. Expression of Nestin - a stem cell associated intermediate filament in human CNS tumors. Indian J Med Res. 2006; 124: 269-280.
  23. Chinnaiyan P, Wang M, Rojiani AM, Tofilon PJ, Chakravarti A, et al. The prognostic value of Nestin expression in newly diagnosed glioblastoma: report from the Radiation Therapy Oncology Group. Radiat Oncol. 2008; 3: 32. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18817556
  24. Kim KJ, Lee KH, Kim HS, Moon KS, Jung TY, et al. The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas. Neuropathology Oct. 2011; 31: 494-502. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21269333

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Similar Articles

  • Immunohistochemical expression of Nestin as Cancer Stem Cell Marker in gliomas
    Rasha Mokhtar Abdelkareem*, Afaf T Elnashar, Khaled Nasser Fadle and Eman MS Muhammad Rasha Mokhtar Abdelkareem*,Afaf T Elnashar,Khaled Nasser Fadle,Eman MS Muhammad. Immunohistochemical expression of Nestin as Cancer Stem Cell Marker in gliomas. . 2019 doi: 10.29328/journal.jnnd.1001027; 3: 162-166
  • Pediatric brainstem glioma
    Ghita Hatim*, Tarik Chekrine, Majdouline Houjami, Mouna Boughafour, Zineb Bouchbika, Nadia Benchakroun, Hassan Jouhadi, Nezha Tawfiq, Abdelatif Benider and Souha Sahraoui Ghita Hatim*,Tarik Chekrine,Majdouline Houjami,Mouna Boughafour,Zineb Bouchbika,Nadia Benchakroun,Hassan Jouhadi,Nezha Tawfiq,Abdelatif Benider,Souha Sahraoui. Pediatric brainstem glioma. . 2022 doi: 10.29328/journal.jnnd.1001059; 6: 001-004

Recently Viewed

  • Difference in Injury Risk between Male and Female Alpine Skiers: Review of the Literature
    Brittany Ammerman*, Margot Richards, Ryann Davie, Natalie Pahapill and Karen Sutton Brittany Ammerman*, Margot Richards, Ryann Davie, Natalie Pahapill, Karen Sutton. Difference in Injury Risk between Male and Female Alpine Skiers: Review of the Literature. J Sports Med Ther. 2024: doi: 10.29328/journal.jsmt.1001075; 9: 011-014
  • Is there a Place for Klotho in Alzheimer’s disease?
    Maria Isabel Saiz-Figuerez, Nava E and Galindo MF and Joaquin Jordan* Maria Isabel Saiz-Figuerez, Nava E, Galindo MF and Joaquin Jordan*. Is there a Place for Klotho in Alzheimer’s disease?. J Sports Med Ther. 2024: doi: 10.29328/journal.jsmt.1001074; 9: 001-010
  • Vitamin D Deficiency and its Correlation with the Severity of Heart Disease in Dilated Cardiomyopathy Patients
    Kuldeep Kumar Gaur*, LH Ghotekar, Shubha Laxmi Margekar, Tarun Kumar and Ritu Singh Kuldeep Kumar Gaur*, LH Ghotekar, Shubha Laxmi Margekar, Tarun Kumar, Ritu Singh. Vitamin D Deficiency and its Correlation with the Severity of Heart Disease in Dilated Cardiomyopathy Patients. J Cardiol Cardiovasc Med. 2023: doi: 10.29328/journal.jccm.1001154; 8: 059-064
  • Aortic dissection complicating carotid dissection and myocardial infarction
    Sung-Yuan Hu*, Chun-Cheng Chen and Hung-Wen Tsai Sung-Yuan Hu*,Chun-Cheng Chen,Hung-Wen Tsai. Aortic dissection complicating carotid dissection and myocardial infarction. J Clin Med Exp Images. 2021: doi: 10.29328/journal.jcmei.1001019; 5: 003-003
  • Navigating Diagnostic Dilemmas in Subacute Subdural Hemorrhage: A Case Report
    Alicia Cárdenas García*, Sara García Mateo, María Sol González Bennike, Berta Alonso García, María Teresa Gómez Álvarez, Francisco de Borja Hernández Moreno and Clara Ponce Aceituno Alicia Cárdenas García*, Sara García Mateo, María Sol González Bennike, Berta Alonso García, María Teresa Gómez Álvarez, Francisco de Borja Hernández Moreno, Clara Ponce Aceituno. Navigating Diagnostic Dilemmas in Subacute Subdural Hemorrhage: A Case Report. Arch Case Rep. 2024: doi: 10.29328/journal.acr.1001091; 8: 039-041

Read More

Most Viewed

Read More

Help ?